upcoming glp 1 drugs GLP-1 Market Trends and Global Forecasts Report 2025: A $157.5 Bn Market by 2035 Medicare GLP-1 Drug Coverage -

This section discusses general scientific concepts and does not constitute an endorsement of any specific product or clinical claim

All participants who received at least one dose of the study medication (semaglutide or metformin) were included in the safety analyses

The Journal of Pharmacology and Experimental Therapeutics

2 A few case reports of acute kidney injury have also been seen with liraglutide in patients who had preexisting renal insufficiency

doi: 10.1038/s41586-018-0849-9 6 YustaBBaggioLLKoehlerJHollandDCaoXPinnellLJet al

For different GLP-1 RAs, the data limits during data retraction were coinciding with their respective first approval date (Table S3)